By Teresa Bitetti
This article originally appeared on LinkedIn on April 27, 2021
Two years ago, after 20-plus years working at the same company, I decided to take on a leadership role at a new organization: President of the Global Oncology Business Unit of Takeda.
While I was new to Takeda, Takeda was not new to me. I had been following the company’s progression in oncology since the acquisition of Millennium, observing from a distance as Takeda brought new therapies to market that were truly game-changing for patients. I had the feeling that they were on the brink of something special. The budding pipeline and network of dynamic partnerships, coupled with the commitment from leaders to make a difference in oncology, was inspiring. Before me was an amazing opportunity to help Takeda realize its best-in-class potential in oncology.
Now, two years later, we have reached an inflection point where we are poised to realize the potential of our pipeline and redefine what’s possible for those living with cancer. What we as a team have been able to achieve in a relatively short amount of time is nothing short of astounding:
During my tenure, I can proudly say that the team’s passion for pushing the boundaries of science for the good of patients everywhere is palpable. It is this focus that inspires, excites and energizes me, and it’s what will ultimately enable us to deliver on our aspiration to cure cancer. I can’t wait to see what we accomplish in the next two years!